Increased circulating inflammatory endothelial cells in blacks with essential hypertension

Hypertension

Volumn 62, Issue 3, 2013, Pages 585-591

  Eirin, Alfonso ^a   Zhu, Xiang Yang ^a   Woollard, John R ^a   Herrmann, Sandra M ^a   Gloviczki, Monika L ^a   Saad, Ahmed ^a   Juncos, Luis A ^b   Calhoun, David A ^c   Rule, Andrew D ^a   Lerman, Amir ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

blacks; hypertension; inflammation; progenitor cells

Indexed keywords

ADIPONECTIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD34 ANTIGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; INFERIOR CAVA VEIN; KIDNEY VEIN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; STEM CELL;

BLACKS; HYPERTENSION; INFLAMMATION; PROGENITOR CELLS;

ADULT; AFRICAN AMERICANS; AGED; AMINE OXIDASE (COPPER-CONTAINING); ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOOD PRESSURE; CELL ADHESION MOLECULES; CELL COUNT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM;

EID: 84883290671     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01621     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation. 2012;125:e2-e220.
2. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1988;12:285-290.
3. Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. BMJ. 1994;308:1011-1014.
4. Folsom AR, Burke GL, Byers CL, Hutchinson RG, Heiss G, Flack JM, Jacobs DR Jr, Caan B. Implications of obesity for cardiovascular disease in blacks: The CARDIA and ARIC studies. Am J Clin Nutr. 1991;53(6 suppl):1604S-1611S.
5. Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension. 2004;43:707-713.
6. Palmer IM, Schutte AE, Huisman HW. Uric acid and the cardiovascular profile of African and Caucasian men. J Hum Hypertens. 2010;24:639-645.
7. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension. 2002;40:903-908.
8. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175-1184.
9. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329:841-845.
10. Lipkowitz MS, Freedman BI, Langefeld CD, et al.; SK Investigators. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int. 2013;83:114-120.
11. Murea M, Freedman BI. Essential hypertension and risk of nephropathy: A reappraisal. Curr Opin Nephrol Hypertens. 2010;19:235-241.
12. de la Sierra A, Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Hum Hypertens. 2010;24:373-379.
13. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA. 2000;97:3479-3484.
14. Coutinho T, Turner ST, Mosley TH, Kullo IJ. Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites. Am J Hypertens. 2012;25:145-151.
15. Lee DS, Larson MG, Lunetta KL, Dupuis J, Rong J, Keaney JF Jr, Lipinska I, Baldwin CT, Vasan RS, Benjamin EJ. Clinical and genetic correlates of soluble P-selectin in the community. J Thromb Haemost. 2008;6:20-31.
16. Holmén C, Elsheikh E, Stenvinkel P, Qureshi AR, Pettersson E, Jalkanen S, Sumitran-Holgersson S. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol. 2005;16:3110-3120.
17. Gulati R, Jevremovic D, Witt TA, Kleppe LS, Vile RG, Lerman A, Simari RD. Modulation of the vascular response to injury by autologous bloodderived outgrowth endothelial cells. Am J Physiol Heart Circ Physiol. 2004;287:H512-H517.
18. Eirin A, Gloviczki ML, Tang H, Gössl M, Jordan KL, Woollard JR, Lerman A, Grande JP, Textor SC, Lerman LO. Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J. 2013;34:540-548a.
19. Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard JR, Lerman A, Textor SC, Lerman LO. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Nephrol Dial Transplant. 2012;27:4153-4161.
20. Heidenreich PA, Trogdon JG, Khavjou OA, et al. American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011;123:933-944.
21. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098-2104.
22. Frohlich ED. Hemodynamic differences between black patients and white patients with essential hypertension. State of the art lecture. Hypertension. 1990;15(6 pt 2):675-680.
23. Cohn HI, Xi Y, Pesant S, Harris DM, Hyslop T, Falkner B, Eckhart AD. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension. 2009;54:71-76.
24. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension. 1999;34:1193-1196.
25. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
26. Torun D, Ozelsancak R, Yiǧit F, Micozkadioǧlu H. Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients. Clin Exp Hypertens. 2012;34:171-175.
27. Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectinindependent recognition of vascular endothelium in human lymph nodes. J Exp Med. 1997;186:589-600.
28. Jalkanen S, Salmi M. Cell surface monoamine oxidases: Enzymes in search of a function. EMBO J. 2001;20:3893-3901.
29. Li HY, Jiang YD, Chang TJ, Wei JN, Lin MS, Lin CH, Chiang FT, Shih SR, Hung CS, Hua CH, Smith DJ, Vanio J, Chuang LM. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes. 2011;60:993-999.
30. Lin MS, Li HY, Wei JN, Lin CH, Smith DJ, Vainio J, Shih SR, Chen YH, Lin LC, Kao HL, Chuang LM, Chen MF. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem. 2008;41:1362-1367.
31. Koc-Zorawska E, Malyszko J, Malyszko JS, Mysliwiec M. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney Allograft recipients. Kidney Blood Press Res. 2012;36:242-247.
32. Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Kashem AM, Brown MD. Endothelial-dependent flowmediated dilation in African Americans with masked-hypertension. Am J Hypertens. 2011;24:1102-1107.
33. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: Predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511-2517.
34. Textor SC, Gloviczki ML, Flessner MF, Calhoun DA, Glockner J, Grande JP, McKusick MA, Cha SS, Lerman LO. Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites. Am J Kidney Dis. 2012;59:229-237.
35. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, Simari RD. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res. 2003;93:1023-1025.
36. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, Lerman A, Vile RG, Simari RD. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation. 2003;108:1520-1526.
37. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434-438.
38. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvàth T, Jiang H, Sorrentino SA, Steenken N, Manes C, Marzilli M, Rudolph KL, Lüscher TF, Drexler H, Landmesser U. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: Relation to endothelial dysfunction. Hypertension. 2010;55:1389-1397.
39. Farah R, Khamisy-Farah R, Shurtz-Swirski R. Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients. Int Angiol. 2013;32:85-93.
40. Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza J, Nicolau JC, Ramires JA, Serrano CV Jr. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis. 2004;177:161-166.
41. Di Raimondo D, Tuttolomondo A, Buttà C, Miceli S, Licata G, Pinto A. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des. 2012;18:4385-4413.